Wenbo Yu

2.3k total citations
82 papers, 1.6k citations indexed

About

Wenbo Yu is a scholar working on Molecular Biology, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Wenbo Yu has authored 82 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 28 papers in Neurology and 17 papers in Cellular and Molecular Neuroscience. Recurrent topics in Wenbo Yu's work include Parkinson's Disease Mechanisms and Treatments (26 papers), Neurological disorders and treatments (9 papers) and Ginkgo biloba and Cashew Applications (8 papers). Wenbo Yu is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (26 papers), Neurological disorders and treatments (9 papers) and Ginkgo biloba and Cashew Applications (8 papers). Wenbo Yu collaborates with scholars based in China, United States and Canada. Wenbo Yu's co-authors include Long Yu, Bao‐Guo Xiao, Lihuan Cao, Jian Wang, Suqin Shen, Jian Wang, Jian Wu, James B. Koprich, Sheng Chen and Jie Tang and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Brain.

In The Last Decade

Wenbo Yu

78 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenbo Yu China 25 728 369 218 202 168 82 1.6k
Heather L. Martin United Kingdom 18 689 0.9× 346 0.9× 217 1.0× 212 1.0× 71 0.4× 29 1.9k
Melissa Vos United States 21 896 1.2× 314 0.9× 313 1.4× 307 1.5× 102 0.6× 29 1.6k
Leonor Miller‐Fleming United Kingdom 16 933 1.3× 223 0.6× 264 1.2× 178 0.9× 94 0.6× 20 1.5k
Ping Deng United States 28 1.0k 1.4× 185 0.5× 653 3.0× 299 1.5× 102 0.6× 80 2.1k
Eun Jin Yang South Korea 21 499 0.7× 216 0.6× 108 0.5× 215 1.1× 84 0.5× 47 1.4k
E. Ellen Billett United Kingdom 28 618 0.8× 247 0.7× 293 1.3× 185 0.9× 133 0.8× 65 1.8k
Ana Cristina Calvo Spain 26 760 1.0× 520 1.4× 363 1.7× 269 1.3× 91 0.5× 65 2.0k
Sangeeta Nath India 23 796 1.1× 275 0.7× 232 1.1× 506 2.5× 310 1.8× 50 1.8k
Hyunkyoung Lee South Korea 25 688 0.9× 112 0.3× 275 1.3× 232 1.1× 67 0.4× 71 2.0k

Countries citing papers authored by Wenbo Yu

Since Specialization
Citations

This map shows the geographic impact of Wenbo Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenbo Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenbo Yu more than expected).

Fields of papers citing papers by Wenbo Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenbo Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenbo Yu. The network helps show where Wenbo Yu may publish in the future.

Co-authorship network of co-authors of Wenbo Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Wenbo Yu. A scholar is included among the top collaborators of Wenbo Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenbo Yu. Wenbo Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yu, Wenbo, Yiqi Liu, Wanbing Zhao, et al.. (2025). Assessing Plasma APLP1 for the Progression of Parkinson's Disease: Insights from HSPD and PPMI Cohorts. Movement Disorders. 40(5). 969–974.
3.
Sun, Yi‐Min, Xinyue Zhou, Fengtao Liu, et al.. (2025). The homozygous LRRK2.p.N1437D point mutation mouse is a novel model of parkinsonism. npj Parkinson s Disease. 11(1). 61–61. 1 indexed citations
4.
Shen, Cong, Bo Shen, Dechen Liu, et al.. (2024). Bidirectional regulation of levodopa-induced dyskinesia by a specific neural ensemble in globus pallidus external segment. Cell Reports Medicine. 5(6). 101566–101566. 4 indexed citations
5.
Zhao, Wanbing, Yun Fan, Qinyue Zhao, et al.. (2024). Tracing TMEM106B fibril deposition in aging and Parkinson’s disease with dementia brains. PubMed. 3(1). lnae011–lnae011. 2 indexed citations
6.
Yu, Wenbo, et al.. (2024). Association between BMI and outcomes in critically ill patients: an analysis of the MIMIC-III database. Scientific Reports. 14(1). 31127–31127.
7.
Yu, Wenbo, et al.. (2024). Editable-DeepSC: Cross-Modal Editable Semantic Communication Systems. 1–5. 1 indexed citations
8.
Fang, Xiaoxue, et al.. (2023). Anti-Colorectal Cancer Activity of Solasonin from Solanum nigrum L. via Histone Deacetylases-Mediated p53 Acetylation Pathway. Molecules. 28(18). 6649–6649. 2 indexed citations
9.
Bu, Lu-Lu, Yan Shen, Yun Fan, et al.. (2021). Neuroprotection of Exendin-4 by Enhanced Autophagy in a Parkinsonian Rat Model of α-Synucleinopathy. Neurotherapeutics. 18(2). 962–978. 38 indexed citations
10.
Sun, Yi‐Min, Huiling Yu, Weixi Xiong, et al.. (2020). Disease Progression in Patients with Parkin‐Related Parkinson's Disease in a Longitudinal Cohort. Movement Disorders. 36(2). 442–448. 17 indexed citations
11.
Shen, Yan, Wenbo Yu, Bo Shen, et al.. (2020). Propagated α-synucleinopathy recapitulates REM sleep behaviour disorder followed by parkinsonian phenotypes in mice. Brain. 143(11). 3374–3392. 52 indexed citations
12.
Ding, Donglin, Huixing Huang, Quanfu Li, et al.. (2020). NF90 stabilizes cyclin E1 mRNA through phosphorylation of NF90-Ser382 by CDK2. Cell Death Discovery. 6(1). 3–3. 5 indexed citations
13.
Chen, Yanfei, Jiang Bian, Lu-Lu Bu, et al.. (2020). Design, synthesis and identification of N, N-dibenzylcinnamamide (DBC) derivatives as novel ligands for α-synuclein fibrils by SPR evaluation system. Bioorganic & Medicinal Chemistry. 28(7). 115358–115358. 12 indexed citations
14.
Yu, Wenbo, Qing Wang, Sheng Chen, et al.. (2019). The therapeutic potential of ginkgolide K in experimental autoimmune encephalomyelitis via peripheral immunomodulation. International Immunopharmacology. 70. 284–294. 16 indexed citations
15.
Song, Jie, Jianying Xi, Wenbo Yu, et al.. (2019). Inhibition of ROCK activity regulates the balance of Th1, Th17 and Treg cells in myasthenia gravis. Clinical Immunology. 203. 142–153. 24 indexed citations
16.
Kang, Zhiwei, et al.. (2017). The identification and expression analysis of candidate chemosensory genes in the bird cherry-oat aphid Rhopalosiphum padi (L.). Bulletin of Entomological Research. 108(5). 645–657. 11 indexed citations
17.
Zhu, Bo, Quanze He, Jingjing Xiang, et al.. (2017). Quantitative Phosphoproteomic Analysis Reveals Key Mechanisms of Cellular Proliferation in Liver Cancer Cells. Scientific Reports. 7(1). 10908–10908. 8 indexed citations
18.
Li, Yanhua, Jingwen Yu, Wenbo Yu, et al.. (2016). Fasudil Enhances Therapeutic Efficacy of Neural Stem Cells in the Mouse Model of MPTP-Induced Parkinson’s Disease. Molecular Neurobiology. 54(7). 5400–5413. 22 indexed citations
19.
Wu, Jian, Wenbo Yu, Yan Chen, et al.. (2009). Intrastriatal Transplantation of GDNF-engineered BMSCs and its neuroprotection in Lactacystin-induced Parkinsonian Rat Model. Neurochemical Research. 35(3). 495–502. 30 indexed citations
20.
Cao, Lihuan, Wenbo Yu, Yanhua Wu, & Long Yu. (2009). The evolution, complex structures and function of septin proteins. Cellular and Molecular Life Sciences. 66(20). 3309–3323. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026